Celularity Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2022	2021	2020	2019
Cash & Equivalents	28.8	52.08	69.51	43.51
Short-Term Investments	2.51	2.49	5.42	0
Cash & Cash Equivalents	31.32	54.56	74.93	43.51
Cash Growth	-42.61%	-27.18%	72.22%	-
Receivables	4.45	2.75	1.13	3.08
Inventory	28.26	12.27	5.85	7.24
Other Current Assets	-30.52	-10.48	-9.75	-17.02
Total Current Assets	33.5	59.1	72.16	36.81
Property, Plant & Equipment	88.72	90.63	90.08	66.39
Goodwill and Intangibles	240.69	246.49	248.68	398.54
Other Long-Term Assets	38.16	17.91	20.09	19.77
Total Long-Term Assets	367.56	355.03	358.85	484.69
Total Assets	401.07	414.13	431.01	521.5
Accounts Payable	5.81	9.32	5.39	3.69
Deferred Revenue	4.49	4.07	12.45	3.83
Current Debt	37.6	3.05	3.01	0
Other Current Liabilities	14.18	9.79	5.83	13.11
Total Current Liabilities	62.09	26.23	26.68	20.64
Long-Term Debt	27.99	28.09	27.63	28.06
Other Long-Term Liabilities	112.09	260.4	357.98	334.94
Total Long-Term Liabilities	140.08	288.49	385.62	363
Total Liabilities	202.17	314.71	412.3	383.63
Total Debt	65.59	31.14	30.64	28.06
Debt Growth	110.65%	1.61%	9.19%	-
Retained Earnings	-645.5	-663.68	-563.56	-355.33
Comprehensive Income	0.01	0	0	0
Shareholders' Equity	198.9	99.42	-531.4	-327.42
Net Cash / Debt	-34.27	23.43	44.29	15.45
Net Cash / Debt Growth	-	-47.10%	186.74%	-
Net Cash Per Share	-2.29	3.49	24.05	6.47
Working Capital	-28.59	32.88	45.48	16.17
Book Value Per Share	14.22	14.83	-288.52	-137.15

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).